FDA Hosts Public Workshop on Partial Gland Ablation for Prostate Cancer at AUA Annual Meeting

Summary

The Food and Drug Administration (FDA) is hosting a public workshop titled "AUA-FDA-SUO Workshop on Partial Gland Ablation for Prostate Cancer" as part of the American Urological Association (AUA) annual meeting in New Orleans, LA, to discuss technologies and imaging used in partial gland ablation for prostate cancer and design clinical trials to measure the most appropriate endpoints.